NEWS BRIEF: JD Logistics swings to profit, but evicted from index

2618.HK

JD Logistics Inc. (2618.HK), the logistics arm of e-commerce giant JD.com (JD.US; 9618.HK) announced strong interim results last Friday, the same day it got kicked out of a major stock index. The company said its revenue grew 11% year-on-year to 86.4 billion yuan ($12.1 billion) in the first six months of 2024. It posted a profit of 2.26 billion yuan for the period, against a loss of 637 million yuan a year earlier.  

The same day it released the report, it was replaced by competitor J&T Express (1519.HK), backed by Tencent, as a component off the Hang Seng China Enterprises Index. Despite that bad news, the positive earnings report helped to lift JD Logistics’ shares by 4.85% to HK$9.95 by the midday break in the Hong Kong trading day.

Reporting by Teri Yu

To subscribe to Bamboo Works free weekly newsletter, click here

,
, ,

Related Articles

RELATED ARTICLES

No related posts.

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Illustration of Luckin and Costa coffee being tasted

Luckin Coffee eyes global leap as China’s Double 11 loses its luster

Luckin could be preparing a bid for Costa Coffee. What's driving this potential deal, and what are its chances for success? And this year's Double 11 festival looks like a dud, with most big e-commerce companies failing to publish any big numbers. What does the future hold for this fast-fading shopping fest?
So-Young runs cosmetic surgery clinics

Can So-Young find new youth in bricks and mortar?

The cosmetic surgery specialist’s top line is growing as it opens new ‘light medical aesthetic’ clinics, but its bottom line is sagging as its older platform business evaporates Key Takeaways:…
SY.US
CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

The pharmaceutical giant is paying the price for its aggressively low bids in China’s centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: The…
1093.HK